These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1651 related items for PubMed ID: 14638348

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Do distinct dyspepsia subgroups exist in the community? A population-based study.
    Choung RS, Locke GR, Schleck CD, Zinsmeister AR, Talley NJ.
    Am J Gastroenterol; 2007 Sep; 102(9):1983-9. PubMed ID: 17581264
    [Abstract] [Full Text] [Related]

  • 27. Is there a difference between abdominal pain and discomfort in moderate to severe IBS patients?
    Sach J, Bolus R, Fitzgerald L, Naliboff BD, Chang L, Mayer EA.
    Am J Gastroenterol; 2002 Dec; 97(12):3131-8. PubMed ID: 12492200
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Mucosal immune activation in irritable bowel syndrome: gender-dependence and association with digestive symptoms.
    Cremon C, Gargano L, Morselli-Labate AM, Santini D, Cogliandro RF, De Giorgio R, Stanghellini V, Corinaldesi R, Barbara G.
    Am J Gastroenterol; 2009 Feb; 104(2):392-400. PubMed ID: 19174797
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Irritable bowel syndrome: a 10-yr natural history of symptoms and factors that influence consultation behavior.
    Ford AC, Forman D, Bailey AG, Axon AT, Moayyedi P.
    Am J Gastroenterol; 2008 May; 103(5):1229-39; quiz 1240. PubMed ID: 18371141
    [Abstract] [Full Text] [Related]

  • 33. Characteristics, diagnostic and symptom profile of patients receiving tegaserod in routine clinical practice in Canada.
    Bradette M, Wawer AR, Balshaw R, Kelly S, Barbeau M, Sambrook R.
    Can J Clin Pharmacol; 2007 May; 14(3):e291-300. PubMed ID: 18025544
    [Abstract] [Full Text] [Related]

  • 34. Gastrointestinal symptoms and subjects cluster into distinct upper and lower groupings in the community: a four nations study.
    Talley NJ, Holtmann G, Agréus L, Jones M.
    Am J Gastroenterol; 2000 Jun; 95(6):1439-47. PubMed ID: 10894576
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Treatment of irritable bowel syndrome. A case control experience.
    Astegiano M, Pellicano R, Terzi E, Simondi D, Rizzetto M.
    Minerva Gastroenterol Dietol; 2006 Dec; 52(4):359-63. PubMed ID: 17108865
    [Abstract] [Full Text] [Related]

  • 39. Altered rectal perception in irritable bowel syndrome is associated with symptom severity.
    Posserud I, Syrous A, Lindström L, Tack J, Abrahamsson H, Simrén M.
    Gastroenterology; 2007 Oct; 133(4):1113-23. PubMed ID: 17919487
    [Abstract] [Full Text] [Related]

  • 40. Symptom patterns in functional dyspepsia and irritable bowel syndrome: relationship to disturbances in gastric emptying and response to a nutrient challenge in consulters and non-consulters.
    Haag S, Talley NJ, Holtmann G.
    Gut; 2004 Oct; 53(10):1445-51. PubMed ID: 15361493
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 83.